{
    "nctId": "NCT01983982",
    "briefTitle": "Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms",
    "officialTitle": "Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms in Early Stage Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Chronic Pain",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Feasibility of recruiting patients at chemotherapy initiation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female gender\n* Histologically proven stage I-III invasive carcinoma of the breast who is planning to receive a standard dose of adjuvant chemotherapy.\n* Surgical resection should be complete at the time of study enrollment.\n* Eastern Cooperative Oncology Group performance status 0-2.\n\nExclusion Criteria:\n\n* Average pain over the past 24 hours of 4 or greater on a 0-10 scale.\n* Peripheral sensory neuropathy grade 2 or higher.\n* Personal history of schizophrenia or major depressive disorder, or history of suicidal ideation or attempt within the past 2 years.\n* Thumbnail abnormalities on either hand (such as artificial nails) that are likely to alter pain perception during testing.\n* Pregnant or nursing.\n* No prior chemotherapy for any reason",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}